gamma-Secretase: characterization and implication for Alzheimer disease therapy

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Alzheimer's disease (AD) is linked to Abeta peptides, generated by gamma-secretase cleavage of amyloid precursor protein.
• Gamma-secretase is a membrane-bound protease with a poorly understood active site.

Purpose of the Study:

• To characterize and identify the gamma-secretase protease.
• To investigate the role of presenilin-1 (PS1) in gamma-secretase activity.
• To explore gamma-secretase as a therapeutic target for AD.

Main Methods:

• Development of an in vitro gamma-secretase assay using a recombinant C100Flag substrate.
• Biochemical characterization of the protease complex.
• Inhibition studies using a photoreactive active site-directed inhibitor.

Main Results:

• Gamma-secretase activity was confirmed to be catalyzed by a macromolecular complex containing PS1.
• Photoreactive inhibitor labeling strongly suggests PS1 contains the active site of gamma-secretase.
• The study provides biochemical evidence for PS1's role in gamma-secretase function.

Conclusions:

• Presenilin-1 (PS1) is a key component of the gamma-secretase complex and likely contains its active site.
• This finding positions PS1/gamma-secretase as a significant therapeutic target for Alzheimer's disease.
• The study contributes to understanding regulated intramembrane proteolysis.